PRUDENTIAL FINANCIAL INC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 166 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRUDENTIAL FINANCIAL INC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,726,894
-29.2%
575,440
-18.6%
0.01%
-21.4%
Q2 2023$9,504,822
-23.0%
707,204
-5.0%
0.01%
-26.3%
Q1 2023$12,345,618
-18.7%
744,609
-8.8%
0.02%
-26.9%
Q4 2022$15,194,154
-20.7%
816,890
-45.3%
0.03%
-18.8%
Q3 2022$19,149,000
+112.9%
1,492,625
+16.3%
0.03%
+128.6%
Q2 2022$8,994,000
-24.0%
1,283,045
-10.1%
0.01%
-12.5%
Q1 2022$11,833,000
+39.5%
1,427,445
+13.9%
0.02%
+45.5%
Q4 2021$8,484,000
-3.3%
1,253,200
-24.3%
0.01%
-8.3%
Q3 2021$8,776,000
-20.9%
1,655,752
-14.2%
0.01%
-20.0%
Q2 2021$11,095,000
-12.5%
1,929,486
-29.8%
0.02%
-21.1%
Q1 2021$12,674,000
+42.1%
2,749,179
+2.9%
0.02%
+26.7%
Q4 2020$8,921,000
+22.7%
2,671,337
+9.1%
0.02%
+7.1%
Q3 2020$7,270,000
+10.7%
2,447,837
+72.2%
0.01%
+7.7%
Q2 2020$6,568,000
+65.7%
1,421,749
+38.1%
0.01%
+44.4%
Q1 2020$3,963,000
-40.3%
1,029,468
-41.9%
0.01%
-10.0%
Q4 2019$6,642,000
+18.6%
1,771,283
+68.0%
0.01%
+11.1%
Q3 2019$5,599,000
+236.9%
1,054,476
+143.6%
0.01%
+200.0%
Q2 2019$1,662,000
+230.4%
432,929
+338.4%
0.00%
+200.0%
Q1 2019$503,000
+87.7%
98,744
-29.4%
0.00%
Q4 2018$268,000
-67.8%
139,878
-36.5%
0.00%
-100.0%
Q3 2018$833,000
-13.2%
220,403
-28.4%
0.00%0.0%
Q2 2018$960,000
+131.3%
307,870
+77.3%
0.00%0.0%
Q1 2018$415,000
-11.5%
173,670
+44.5%
0.00%0.0%
Q4 2017$469,000120,1700.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders